XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,010,701 | +127.9% | 101,717 | +108.7% | 0.08% | +65.2% |
Q3 2022 | $1,760,000 | +425.4% | 48,750 | +342.3% | 0.05% | +206.7% |
Q2 2022 | $335,000 | -60.1% | 11,023 | -59.9% | 0.02% | -59.5% |
Q1 2022 | $840,000 | +290.7% | 27,468 | +299.4% | 0.04% | +208.3% |
Q4 2021 | $215,000 | – | 6,878 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |